- Home
- UPB vs NESR Comparison
UPB vs NESR Comparison
Compare UPB & NESR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- NESR
- Stock Information
- Founded
- UPB 2021
- NESR 2017
- Country
- UPB United States
- NESR United States
- Employees
- UPB N/A
- NESR N/A
- Industry
- UPB
- NESR
- Sector
- UPB
- NESR
- Exchange
- UPB NYSE
- NESR NYSE
- Market Cap
- UPB 521.3M
- NESR 597.0M
- IPO Year
- UPB 2024
- NESR N/A
- Fundamental
- Price
- UPB $10.89
- NESR $6.37
- Analyst Decision
- UPB Strong Buy
- NESR Strong Buy
- Analyst Count
- UPB 4
- NESR 4
- Target Price
- UPB $56.50
- NESR $15.00
- AVG Volume (30 Days)
- UPB 502.4K
- NESR 1.1M
- Earning Date
- UPB 08-14-2025
- NESR 08-11-2025
- Dividend Yield
- UPB N/A
- NESR N/A
- EPS Growth
- UPB N/A
- NESR 214.19
- EPS
- UPB N/A
- NESR 0.80
- Revenue
- UPB $2,296,000.00
- NESR $1,307,958,000.00
- Revenue This Year
- UPB N/A
- NESR $5.40
- Revenue Next Year
- UPB N/A
- NESR $7.43
- P/E Ratio
- UPB N/A
- NESR $7.98
- Revenue Growth
- UPB N/A
- NESR 11.45
- 52 Week Low
- UPB $5.14
- NESR $5.20
- 52 Week High
- UPB $29.46
- NESR $9.89
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- NESR N/A
- Support Level
- UPB N/A
- NESR N/A
- Resistance Level
- UPB N/A
- NESR N/A
- Average True Range (ATR)
- UPB 0.00
- NESR 0.00
- MACD
- UPB 0.00
- NESR 0.00
- Stochastic Oscillator
- UPB 0.00
- NESR 0.00
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
About NESR NATIONAL ENERGY SVCS REUNITED CORP
National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well. It derives maximum revenue from Production services segment.